Robin van der Lee is a Senior Research Scientist specializing in protein engineering at AbCellera, where they lead a team in silico assessing antibodies for drug discovery programs. With a PhD in comparative and integrative genomics, Robin has over 15 years of experience in bioinformatics, contributing to multiple antibody drug discovery programs, including treatments for COVID-19. They have authored 25 peer-reviewed publications, accumulating over 6,500 citations. Previously, Robin held roles at Radboud University, MRC Laboratory of Molecular Biology, and The University of British Columbia, engaging in research that spanned genomics, immunology, and clinical genetics.
This person is not in the org chart